Lead party: NATCO Pharma Limited (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Time Cap Overseas Limited (private company) · Sector: Financial Services, Investment Holding & SPVs · Countries of operation: Mauritius
Transaction type: Investment · Asset class: Corporate Transactions · Strategy: Buyout · Instrument: Equity · Deal amount: US$727,100 · Equity stake: 0.061% · Implied EV: US$11.9m
Lead investor/buyer: NATCO Pharma Limited · Investors/buyers: NATCO Pharma Limited
Legal advisers: not identified in the source record.
Source: announced 10 September 2020. Original announcement: nsearchives.nseindia.com.


